Inhaltsbereich
| 25 Einträge | 1, 2 › » |
Seite 1 / 2
 Druckansicht
|
| Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy. |
| Höbaus J, Tennakoon S, Heffeter P, Groeschel C, Aggarwal A, Hummel DM, Thiem U, Marculescu R, Berger W, Kállay E |
| International journal of cancer. Journal international du cancer. 2015 Aug 3. doi: 10.1002/ijc.29717 |
| PMID: 26238339 |
| miR-135b- and miR-146b-dependent silencing of calcium-sensing receptor expression in colorectal tumors. |
| Fetahu IS, Tennakoon S, Lines KE, Gröschel C, Aggarwal A, Mesteri I, Baumgartner-Parzer S, Mader RM, Thakker RV, Kállay E |
| International journal of cancer. Journal international du cancer. 2015 Jul 14. doi: 10.1002/ijc.29681 |
| PMID: 26178670 |
| The calcium-sensing receptor suppresses epithelial-to-mesenchymal transition and stem cell- like phenotype in the colon. |
| Aggarwal A, Prinz-Wohlgenannt M, Gröschel C, Tennakoon S, Meshcheryakova A, Chang W, Brown EM, Mechtcheriakova D, Kállay E |
| Molecular cancer. 2015 Mar 18. doi: 10.1186/s12943-015-0330-4. pii: 10.1186/s12943-015-0330-4. pmc: PMC4405849 |
| PMID: 25879211 |
| Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cells. |
| Gröschel C, Aggarwal A, Tennakoon S, Höbaus J, Prinz-Wohlgenannt M, Marian B, Heffeter P, Berger W, Kállay E |
| The Journal of steroid biochemistry and molecular biology. 2015 Mar 14. pii: S0960-0760(15)00049-7. doi: 10.1016/j.jsbmb.2015.02.011 |
| PMID: 25777538 |
| Active vitamin D potentiates the anti-neoplastic effects of calcium in the colon: A cross talk through the calcium-sensing receptor. |
| Aggarwal A, Höbaus J, Tennakoon S, Prinz-Wohlgenannt M, Graça J, Price SA, Heffeter P, Berger W, Baumgartner-Parzer S, Kállay E |
| The Journal of steroid biochemistry and molecular biology. 2015 Mar 7. pii: S0960-0760(15)00044-8. doi: 10.1016/j.jsbmb.2015.02.006 |
| PMID: 25758239 |
| The calcium-sensing receptor: A promising target for prevention of colorectal cancer. |
| Aggarwal A, Prinz-Wohlgenannt M, Tennakoon S, Höbaus J, Boudot C, Mentaverri R, Brown EM, Baumgartner-Parzer S, Kállay E |
| Biochimica et biophysica acta. 2015 Feb 18. pii: S0167-4889(15)00051-8. doi: 10.1016/j.bbamcr.2015.02.011 |
| PMID: 25701758 |
| The vitamin D system is deregulated in pancreatic diseases. |
| Hummel D, Aggarwal A, Borka K, Bajna E, Kállay E, Horváth HC |
| The Journal of steroid biochemistry and molecular biology. 2014 Jul 30. pii: S0960-0760(14)00135-6. doi: 10.1016/j.jsbmb.2014.07.011. pmc: PMC4217145 |
| PMID: 25090635 |
| Calcium-sensing receptor silencing in colorectal cancer is associated with promoter hypermethylation and loss of acetylation on histone 3. |
| Fetahu IS, Höbaus J, Aggarwal A, Hummel DM, Tennakoon S, Mesteri I, Baumgartner-Parzer S, Kállay E |
| International journal of cancer. Journal international du cancer. 2014 Apr 2. doi: 10.1002/ijc.28856. pmc: PMC4282356 |
| PMID: 24691920 |
| Regulation of the calcium-sensing receptor expression by 1,25-dihydroxyvitamin D3, interleukin-6, and tumor necrosis factor alpha in colon cancer cells. |
| Fetahu IS, Hummel DM, Manhardt T, Aggarwal A, Baumgartner-Parzer S, Kállay E |
| The Journal of steroid biochemistry and molecular biology. 2013 Oct 28. pii: S0960-0760(13)00208-2. doi: 10.1016/j.jsbmb.2013.10.015. pmc: PMC4220008 |
| PMID: 24176760 |
| Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer. |
| Höbaus J, Hummel DM, Thiem U, Fetahu IS, Aggarwal A, Müllauer L, Heller G, Egger G, Mesteri I, Baumgartner-Parzer S, Kallay E |
| International journal of cancer. Journal international du cancer. 2013 Apr 5. doi: 10.1002/ijc.28143. pmc: PMC3807607 |
| PMID: 23463632 |
| The calcium-sensing receptor and the hallmarks of cancer. |
| Tennakoon S, Aggarwal A, Kállay E |
| Biochimica et biophysica acta. 2015 Nov 30. pii: S0167-4889(15)00401-2. doi: 10.1016/j.bbamcr.2015.11.017 |
| PMID: 26608608 |
| Cross Talk between the Calcium-Sensing Receptor and the Vitamin D System in Prevention of Cancer. |
| Aggarwal A, Kállay E |
| Frontiers in physiology. doi: 10.3389/fphys.2016.00451 |
| PMID: 27803671 |
| Expression profiling of colorectal cancer cells reveals inhibition of DNA replication licensing by extracellular calcium. |
| Aggarwal A, Schulz H, Manhardt T, Bilban M, Thakker RV, Kallay E |
| Biochimica et biophysica acta. 2017 Feb 1. pii: S0167-4889(17)30025-3. doi: 10.1016/j.bbamcr.2017.01.017 |
| PMID: 28161520 |
| Developing Innovative, Robust and Affordable Medical Linear Accelerators for Challenging Environments. |
| Dosanjh M, Aggarwal A, Pistenmaa D, Amankwaa-Frempong E, Angal-Kalinin D, Boogert S, Brown D, Carlone M, Collier P, Court L, Di Meglio A, Van Dyk J, Grover S, Jaffray DA, Jamieson C, Khader J, Konoplev I, Makwani H, McIntosh P, Militsyn B, Palta J, Sheehy S, Aruah SC, Syratchev I, Zubizarreta E, Coleman CN |
| Clinical oncology (Royal College of Radiologists (Great Britain)). 2019 Feb 22. pii: S0936-6555(19)30055-X. doi: 10.1016/j.clon.2019.02.002 |
| PMID: 30798993 |
| Switching to a Healthy Diet Prevents the Detrimental Effects of Western Diet in a Colitis-Associated Colorectal Cancer Model. |
| Gröschel C, Prinz-Wohlgenannt M, Mesteri I, Karuthedom George S, Trawnicek L, Heiden D, Aggarwal A, Tennakoon S, Baumgartner M, Gasche C, Lang M, Marculescu R, Manhardt T, Schepelmann M, Kallay E |
| Nutrients. 2019 Dec 23. pii: nu12010045. doi: 10.3390/nu12010045 |
| PMID: 31877961 |
| Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis. |
| Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Nguyen QD, Pavesio C, Gupta V |
| Ophthalmology. 2020 Jan 11. pii: S0161-6420(20)30013-0. doi: 10.1016/j.ophtha.2020.01.008 |
| PMID: 32115264 |
| Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study. |
| Moreau P, Joshua D, Chng WJ, Palumbo A, Goldschmidt H, Hájek R, Facon T, Ludwig H, Pour L, Niesvizky R, Oriol A, Rosiñol L, Suvorov A, Gaidano G, Pika T, Weisel K, Goranova-Marinova V, Gillenwater HH, Mohamed N, Aggarwal S, Feng S, Dimopoulos MA |
| Leukemia. 2016 Aug 5. pii: leu2016186. doi: 10.1038/leu.2016.186 |
| PMID: 27491641 |
| Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR. |
| Chng WJ, Goldschmidt H, Dimopoulos MA, Moreau P, Joshua D, Palumbo A, Facon T, Ludwig H, Pour L, Niesvizky R, Oriol A, Rosiñol L, Suvorov A, Gaidano G, Pika T, Weisel K, Goranova-Marinova V, Gillenwater HH, Mohamed N, Feng S, Aggarwal S, Hájek R |
| Leukemia. 2016 Dec 27. pii: leu2016390. doi: 10.1038/leu.2016.390 |
| PMID: 28025582 |
| Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study. |
| Dimopoulos MA, Stewart AK, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel D, Mihaylov GG, Goranova-Marinova V, Rajnics P, Suvorov A, Niesvizky R, Jakubowiak A, San-Miguel J, Ludwig H, Palumbo A, Obreja M, Aggarwal S, Moreau P |
| British journal of haematology. 2017 Feb 17. doi: 10.1111/bjh.14549 |
| PMID: 28211560 |
| Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup. |
| Ludwig H, Dimopoulos MA, Moreau P, Chng WJ, Goldschmidt H, Hájek R, Facon T, Pour L, Niesvizky R, Oriol A, Rosiñol L, Suvorov A, Gaidano G, Pika T, Weisel K, Goranova-Marinova V, Palumbo A, Gillenwater HH, Mohamed N, Aggarwal S, Feng S, Joshua D |
| Leukemia & lymphoma. 2017 Mar 17. doi: 10.1080/10428194.2017.1298755 |
| PMID: 28306371 |
| 25 Einträge | 1, 2 › » |
Seite 1 / 2
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
